The Science Behind Targeted Treatments and Immunotherapies for Malignant Melanoma
The aim of this morning’s course is to provide an up-to-date overview of targeted treatments and immunotherapies given to people with malignant melanoma. This includes treatment combinations and new approaches currently being investigated in clinical trials.
Elaine’s goal is to explain the science that underpins each treatment and to provide learners with a broad understanding of why treatments work well for some patients but not for others.
This course builds on two mornings on targeted treatments and immunotherapies for solid tumours on 03 & 04 December.
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
To book, contact: email@example.com
View the programme